PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
 
Acta Neuropathol. Jun 2010; 119(6): 755–770.
Published online Mar 3, 2010. doi:  10.1007/s00401-010-0655-4
PMCID: PMC2869041
The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes
Jerzy Wegiel,corresponding author1 Izabela Kuchna,1 Krzysztof Nowicki,1 Humi Imaki,1 Jarek Wegiel,1 Elaine Marchi,1 Shuang Yong Ma,1 Abha Chauhan,5 Ved Chauhan,5 Teresa Wierzba Bobrowicz,6 Mony de Leon,2,3,4,10 Leslie A. Saint Louis,2,3,4,9 Ira L. Cohen,7 Eric London,7 W. Ted Brown,8 and Thomas Wisniewski1,2,3,4
1Department of Developmental Neurobiology, NYS Institute for Basic Research in Developmental Disabilities (IBR), 1050 Forest Hill Road, Staten Island, NY 10314 USA
2Department of Neurology, New York University School of Medicine, New York, NY USA
3Department of Pathology, New York University School of Medicine, New York, NY USA
4Department of Psychiatry, New York University School of Medicine, New York, NY USA
5Department of Neurochemistry, IBR, Staten Island, NY USA
6Department of Neuropathology, Institute of Psychiatry and Neurology, Warsaw, Poland
7Department of Psychology, IBR, Staten Island, NY USA
8Department of Human Genetics, IBR, Staten Island, NY USA
9Corinthian Diagnostic Radiology, New York, NY USA
10Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY USA
Jerzy Wegiel, Phone: +1-718-4945231, Fax: +1-718-9824856, jerzy.wegiel/at/omr.state.ny.us.
corresponding authorCorresponding author.
Received November 12, 2009; Revised February 5, 2010; Accepted February 9, 2010.
Autism is characterized by a broad spectrum of clinical manifestations including qualitative impairments in social interactions and communication, and repetitive and stereotyped patterns of behavior. Abnormal acceleration of brain growth in early childhood, signs of slower growth of neurons, and minicolumn developmental abnormalities suggest multiregional alterations. The aim of this study was to detect the patterns of focal qualitative developmental defects and to identify brain regions that are prone to developmental alterations in autism. Formalin-fixed brain hemispheres of 13 autistic (4–60 years of age) and 14 age-matched control subjects were embedded in celloidin and cut into 200-μm-thick coronal sections, which were stained with cresyl violet and used for neuropathological evaluation. Thickening of the subependymal cell layer in two brains and subependymal nodular dysplasia in one brain is indicative of active neurogenesis in two autistic children. Subcortical, periventricular, hippocampal and cerebellar heterotopias detected in the brains of four autistic subjects (31%) reflect abnormal neuronal migration. Multifocal cerebral dysplasia resulted in local distortion of the cytoarchitecture of the neocortex in four brains (31%), of the entorhinal cortex in two brains (15%), of the cornu Ammonis in four brains and of the dentate gyrus in two brains. Cerebellar flocculonodular dysplasia detected in six subjects (46%), focal dysplasia in the vermis in one case, and hypoplasia in one subject indicate local failure of cerebellar development in 62% of autistic subjects. Detection of flocculonodular dysplasia in only one control subject and of a broad spectrum of focal qualitative neuropathological developmental changes in 12 of 13 examined brains of autistic subjects (92%) reflects multiregional dysregulation of neurogenesis, neuronal migration and maturation in autism, which may contribute to the heterogeneity of the clinical phenotype.
Keywords: Autism, Developmental neuropathology, Subependymal nodular dysplasia, Heterotopia, Dysplasia
Autism is characterized by a broad spectrum of clinical manifestations, including (a) qualitative impairments in reciprocal social interactions, (b) qualitative impairments in verbal and nonverbal communication, (c) restricted repetitive and stereotyped patterns of behavior, interests and activities and (d) onset prior to the age of 3 years [1]. In most cases, the etiology is unknown, and patients are diagnosed with idiopathic or non-syndromic autism [10, 43]. About 70% of individuals with idiopathic autism have essential autism, defined by the absence of physical abnormalities, but in 30%, complex autism with dysmorphic features such as microcephaly and/or a structural brain malformation is diagnosed [79]. In 5–10% of cases, autism is diagnosed in association with other disorders such as fragile X syndrome, Rett syndrome, Down syndrome, and tuberous sclerosis [94, 105]. Intellectual impairments, defined as intelligence quotient (IQ) scores less than 70, were reported in 44.6% of children diagnosed with autism [28]. Epilepsy is observed in up to 33% of individuals with autism [106].
The phenotypic heterogeneity is a major obstacle in all areas of autism research [83] and may be the result of a contribution of non-overlapping gene effects. The genetic fractionation of social impairment, communication difficulties and rigid and repetitive behaviors suggests that different features of autism are caused by different genes associated with different brain regions and are related to different cognitive impairments and functional abnormalities [48].
In spite of the broad spectrum of clinical manifestations and striking inter-individual differences, studies of thousands of children have resulted in establishing the clinical diagnostic criteria of pervasive developmental disorder [1]; however, corresponding neuropathological diagnostic criteria do not exist. One of the reasons for the disproportionate progress in clinical and neuropathological studies is the limited tissue resources available for postmortem studies. Between 1980 and 2003, only 58 brains of individuals with autism were examined [85]. Due to the diversity of research aims, of protocols for tissue preservation and of methods of sampling and examination, and the small number of brains examined in an individual project, the pattern of neuropathological changes emerging from these studies remains incomplete and inconsistent.
The hypothesis that autism is associated with neuropathological changes was explored in the first reports published between 1980 and 1993 [7, 21, 22, 27, 42, 50, 51, 82, 90]. Since then, implementation of broader diagnostic terms such as Autism Spectrum Disorder (ASD), examination of larger cohorts, applications of stereology, and functional and structural magnetic resonance imaging (MRI) have resulted in the detection of several major types of pathology, most likely contributing to the clinical phenotype. An emerging concept of autism-related brain pathology integrates evidence of (a) abnormal acceleration of brain growth in early childhood [89], (b) minicolumn pathology [13, 14], (c) curtailed neuronal development [7, 108] and brain structure-specific delays of neuronal growth [111] with indications of abnormalities in brain cytoarchitecture [4, 7], metabolic modifications with abnormal amyloid protein precursor (APP) processing [5, 101], enhanced oxidative stress [17] and enhanced turnover of cell organelles with pigment accumulation and glial activation [68].
In spite of the conceptual limitations, “localizing” models are still the main approach to the identification of pathological changes as a component of the networks’ structural and functional abnormalities [81]. We hypothesize that dysregulation of neurogenesis, neuronal migration and maturation is also reflected in qualitative, focal, developmental alterations of brain microarchitecture. The aim of this study is to detect the pattern of focal, qualitative, developmental defects in autism brain, including their type, topography and severity, and to identify the structures and brain regions that are prone to developmental alterations in autism.
The autistic cohort study consisted of 13 subjects (4–62 years of age), including 9 males (69%) and 4 females (31%), while the control cohort consisted of 14 subjects (4–64 years of age), including 9 males and 5 females (Table 1).
Table 1
Table 1
Material examined
Clinical and genetic characteristics of the autistic subjects
The source of our clinical data was the medical records of the autistic subjects, which consisted of psychological, behavioral, neurological and psychiatric evaluation reports. All of the records were obtained after the subjects’ deaths. The Autism Diagnostic Interview-Revised (ADI-R) was administered to each donor family as a standardized assessment tool in order to confirm the diagnosis on a postmortem basis. Inclusion of the subject in this study was based on a summary of scores of four domains: (a) qualitative abnormalities in reciprocal social interaction; (b) qualitative abnormalities in verbal and nonverbal communication; (c) restricted, repetitive and stereotyped patterns of behavior; and (d) abnormality of development evident at or before 36 months [69]. All 13 autistic subjects met ADI-R criteria for autism. For some subjects, the intellectual evaluation was available and was based on the Wechsler Intelligence Scale for Children III and the Woodcock-Johnson Tests of Achievement-Revised (Table 2). Eight subjects were diagnosed with intellectual disability, usually in the range from mild to severe (61%). Six of 13 autistic subjects had seizures (46%). In five cases, the age of onset of seizures was from 14 months to 5 years of age. A 23-year-old autistic male had only one seizure, which was reported as the cause of his death. In one child, an abnormal EEG was detected, but without seizures.
Table 2
Table 2
Behavioral and neurological signs, and the type and topography of developmental abnormalities
Several forms of challenging behaviors and behavioral disorders were noted, including self-injurious behavior (six cases, 46%), aggression (four cases, 31%), hyperactivity (three cases, 23%), obsessive compulsive disorder (two cases, 12%) and depression and mania (a single case of each).
For three of the 13 autistic subjects, the list of high-confidence copy number variations identified both by quantiSNAP and Partek HMM computational algorithm was posted on the ATP portal by Drs. Steve Scherer and Richard Wintle from The Center for Applied Genomics, Toronto. The copy number variations detected in the three autistic subjects do not differ from those commonly observed [75], except for the loss of 25,505 kb within Neuropeptide S Receptor 1 (NPSR1) gene at 7p15–p14 detected in a 22-year-old autistic male (B-6337). NPSR1 has not been linked to autism in the genomic reports [103, 112]; however, an association of NPSR1 copy number variation with allergies has been reported [11] that might be linked to the patient’s history of allergies.
Originally, 38 brains, including 20 brains of autistic and 18 brains of control subjects, were assigned to this project. However, application of the clinical and neuropathological exclusion criteria reduced the size of the cohort to 27 brains. Based on the results of the ADI-R, two cases were excluded, including one case diagnosed with atypical autism, and one that did not meet ADI-R criteria. Based on postmortem evaluation, five more autistic cases were excluded: one due to severe postmortem autolytic changes, three due to severe global hypoxic encephalopathy related to the mechanism of death, and one due to multiple microinfarcts. Moreover, four brains of control subjects were disqualified due to severe postmortem autolysis. In all these brains, neuronal loss, changes of neuronal size and shape, and gliosis were so severe that they masked and distorted the qualitative and quantitative characteristics of the developmental alterations associated with autism.
Brain tissue preservation
Brains of 13 autistic and 14 age-matched control subjects were examined by postmortem MRI and neuropathologically. The postmortem interval (PMI) varied, ranging from 6 to 27.8 h in the control group (16 h on average; SD 6 h) and from 8 to 30 h in the autistic group (20 h on average; SD 12 h). The median PMI was 15 h.
The brain hemispheres were removed using standard techniques, exercising extra care to avoid damaging the brain tissue. The brain was weighed in the fresh state. The fresh brain was sagittally cut through the corpus callosum and brainstem. Half of the brain was fixed in 10% buffered formalin. Following at least 3 weeks of fixation, the brain hemisphere was scanned using MRI. The aim of the MRI application was to determine the type of developmental changes detectable by MRI and to microscopically characterize MRI findings. All brains within this project were scanned (L.A.S.L.) using a standardized protocol (established and implemented for this and for other postmortem MRI studies by L.A.S.L. and M.L.). MRI scans were acquired on a 1.5 T GE Signa Imager (General Electric, Milwaukee, USA). The research scan consisted of a 124-slice T1-weighted fast gradient echo acquired in a coronal orientation perpendicular to the long axis of the hippocampus with a 1.5-mm slice thickness, which encompassed the entire brain hemisphere without gaps or wrap artifacts (FOV = 25 cm; NEX = 1; matrix = 256 × 192; TR = 35 ms; FA = 60º). All file names were assigned sequential code numbers, and demographic information was removed from image headers [9]. MRI scans were first screened in a diagnosis–blind manner, and the brains with abnormalities were re-evaluated by both radiologists and neuropathologists to determine the topography, type, and size of lesions detected with both methods
The brain hemisphere was fixed with 10% buffered formalin. Formalin was washed out from the tissue during an overnight tap water rinsing. Brains were dehydrated using a series of increasing ethyl alcohol concentrations (50% ethanol 3 days; 70% ethanol 4 days; 80% ethanol 3 days; 95% ethanol 4 days). The brain hemisphere was embedded in 8% celloidin [53]. During hardening, celloidin blocks were exposed to chloroform vapors for approximately 2.5 weeks, and celloidin blocks were then stored in 70% ethanol. For sectioning, the block was attached to the block holder with 10–15 ml of 8% celloidin. To fasten adhesion of the block to the holder, the block with the holder attached was immersed in 70% ethanol overnight. Serial 200-μm-thick sections were separated with filter paper and stored in 70% ethanol. For the four control and four brains of autistic subjects, alternative series of 200- and 50-μm-thick sections were preserved. To ensure the same probability of detection of changes in each case, every 200-μm-thick section, with a distance 1.2 mm, was used in this project. Sections were washed in water for 2–3 h, stained with cresyl violet (CV) and mounted with Acrytol.
One neuropathologist (I.K.) examined, in a blind-to-diagnosis fashion, on average 120 hemispheric CV-stained sections per case with a 1.2-mm distance between sections. Two-step screening included examination at low magnification (28×) using Zeiss DL2 Documator and microscopic examination using objective lenses from 5× to 100×. Two other neuropathologists (T.W. and J.W.) examined all histological slides for which pathology was detected during the primary screening. The defects of neurogenesis, neuronal migration, and dysplastic changes that they detected were summarized in this report.
Tissue acquisition for this program project is based on individual tissue transfer agreements between the program project’s principal investigator and several tissue banks: (a) the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, (b) the Harvard Brain Tissue Resource Center and (c) the Brain Bank for Developmental Disabilities and Aging of the NYS Institute for Basic Research in Developmental Disabilities. Each brain hemisphere number given by the institution that received the donation was used as the only identifier of clinical records and tissue samples. Brain Bank identification of tissue samples is listed in Tables 1 and and22 to keep non-overlapping records of results of examination of brains in different projects and research groups. The Institutional Review Board of the New York State Institute for Basic Research in Developmental Disabilities approved the methods applied in this study.
Neuropathological evaluation of serial coronal hemispheric sections from the cerebral and cerebellar hemispheres of 13 autistic and 14 control subjects revealed more details characterizing the topography and severity of changes than did standard sampling of brains for routine neuropathological evaluation. A broad range of changes was found. Developmental abnormalities included subependymal nodular dysplasia, heterotopia and very common dysplastic changes within the neo- and archicortex, hippocampus and cerebellum in 12 of 13 examined brains of the autistic subjects (92%) (Table 2). The general result of these developmental defects was a multifocal disorganization of gray and white matter. The developmental pathology observed in control brains was limited to one cerebellar dysplasia.
Alterations of the subependymal cell layer and subependymal nodular dysplasia
In two autistic subjects, there was a several-fold local increase in the thickness of the subependymal cell layer. Numerous subependymal nodules were found within a pathologically thickened subependymal cell layer, in the wall of the occipital horn of the lateral ventricle of a 7-year-old male, which reflects a subependymal nodular dysplasia (Fig. 1a–e). Nodules occupied 13.3 mm of the caudal portion of the occipital horn of the lateral ventricle. The diameter of round/oval nodules varied in size from 285 to 3,310 μm. While the smallest nodules were dispersed within the subependymal cell layer, the large nodules expanded partially into the white matter, and partially into the lumen of the ventricles and were detectable on MRI (Fig. 1a) and CV-stained histological sections (Fig. 1b, c). The effect was narrowing of the ventricle and the tuberous appearance of the ventricular wall. There were large tubers that contained dysplastic neurons with a partially modified morphology of pyramidal, multipolar or bipolar large neurons (Fig. 1d) and irregularly shaped medium and small neurons. Neurons in the small nodules were small and poorly differentiated (Fig. 1e). In the large nodules, several hypocellular areas were observed. The nodules were free of oval or polygonal giant cells or ballooned glial cells, as well as signs of calcification.
Fig. 1
Fig. 1
Nodules in the wall of the lateral ventricle detected in postmortem MRI (a) in the brain of a 7-year-old male diagnosed with autism (B-6403) revealed features of subependymal nodular dysplasia (SND; b) in examination of CV-stained sections. c Numerous (more ...)
In the brain with the subependymal nodular dysplasia, an abnormal tuberous expansion of the caudate nucleus was detected on MRI (Fig. 1f) and in histological sections (Fig. 1g, h). Only the ependyma separated the tuber-like expansion of the caudate from the ventricle lumen. The very thick subependymal cell layer that was present close to the caudate was substituted by loosely arranged and poorly differentiated neurons in the affected area.
Heterotopia
Heterotopias were found in the brains of four autistic subjects and no control subjects. The topography of the lesions was different in each case. Subcortical heterotopias were detected in the white matter of the anterior cingulate gyrus of a 5-year-old (Fig. 2a, b) and in the inferior frontal gyrus in an 11-year-old subject. Periventricular heterotopias were detected near the wall of lateral ventricle in 7-year old subject (Fig. 2c, d). A single heterotopia was noted in the stratum oriens of the hippocampus. In the cerebellum of the 11-year-old subject, heterotopias were detected in the vermis and the cerebellar white matter close to the dentate nucleus (Fig. 2f–h). These defects of migration were observed in two brains as a single aggregate of gray matter, in one brain as two aggregates and in one brain as three lesions measuring from 1 to 3 mm in diameter. Subcortical and periventricular heterotopias comprised poorly differentiated oval or multipolar neurons without spatial orientation (Fig. 2a) or had a distorted laminar organization (Fig. 2e). Cerebellar heterotopias had a distorted morphology of the granule and molecular layers with a few dispersed Purkinje cells (Fig. 2g, h).
Fig. 2
Fig. 2
Large subcortical heterotopia within anterior cingulate gyrus in a 5-year-old autistic child (UMB-1627) (a) contained dysplastic neurons without spatial orientation (b). Periventricular heterotopia near the frontal horn of the lateral ventricle (c MRI, (more ...)
Dysplasia within neocortex and archicortex, hippocampus and cerebellum
The multifocal neocortical dysplasia detected in four brains of autistic subjects (31%) was associated with a local loss of vertical and horizontal organization of the neocortex, formation of abnormal layers, loss of orientation of neurons (Fig. 3a, b) and thickening of the affected portion of the cortical ribbon. A focal dysplasia in the entorhinal cortex, observed mainly in the second layer with a local absence of islands and/or reduced number of neurons, was found in the 23-year-old and the 60-year-old autistic subjects (15%) (Fig. 3c, d). A lack of giant multinuclear neurons and large, ballooned glial cells typical of focal cortical dysplasia indicated that the observed developmental changes in neocortex and archicortex reflect a more subtle cortical malformation, classified usually as focal cortical microdysgenesis.
Fig. 3
Fig. 3
Dysplastic changes within neocortex (a, b), entorhinal cortex (c, d), dentate gyrus (e, f) and the cornu Ammonis (g, h). Focal dysplasia in frontal cortex with loss of vertical and horizontal cytoarchitecture (two arrows) and abnormal (arrowhead) laminar (more ...)
Two types of changes were observed in the dentate gyrus. An abnormal migration of granule neurons into the molecular layer resulted in the formation of an additional fragmentary granule cell layer (Fig. 3e). In other areas, granule cells formed irregular circles and loops (Fig. 3f).
In the CA1 sector of a 13-year-old male, several areas of dysplastic changes with a significant deficit of pyramidal neurons without gliosis were found (Fig. 3g). In affected areas, the size and shape of neurons varied over a wide range. Pyramidal neurons were very rare, whereas small irregular or oval-shaped, poorly differentiated neurons prevailed (Fig. 3h). In the dysplastic area in the CA1 sector of the 56-year-old autistic subject, an opposite trend was present, with thickening of the pyramidal layer and an increased packing of dysplastic neurons (not shown).
The most common developmental abnormality within the cerebellum was dysplasia, which was detected in seven autistic subjects (54%) and in the cerebellum of one control subject.
Flocculonodular dysplasia (Fig. 4a, b), usually affecting the entire nodule, was found in the cerebellum in six autistic subjects (46%). In the dysplastic areas, a thin granule layer formed the labyrinth, which was mixed with irregular islands of the molecular layer. Clusters of granule cells and a few Purkinje cells were dispersed within the distorted molecular layer. The only developmental abnormality detected in the control group was flocculonodular dysplasia in the cerebellum of the 51-year-old control subject (not shown). Local cortical dysplasia was also detected within the vermis of the 13-year-old autistic male. In the affected area, the cytoarchitecture of the molecular and granule layers and the Purkinje cells was completely disorganized (Fig. 4c, d).
Fig. 4
Fig. 4
Flocculonodular dysplasia in cerebellum of 56-year-old autistic subject (B-6276) (a) with thin irregular granule (G) and molecular (M) layer. b Dysplastic granule layer (G), ectopic granule cells (arrow) in the molecular layer, and loosely dispersed Purkinje (more ...)
In the cerebellum of the 60-year-old autistic male, severe hypoplasia affected lobes 1–4 (Fig. 4e). The thickness of the molecular and granular layer was decreased by almost 50% in comparison to that of the non-affected areas (Fig. 4e, f). The number of Purkinje cells was significantly reduced in the hypoplastic area. Hypoplastic changes within the portion of cerebellar cortex were observed, together with a significantly reduced convolution of the dentate nucleus (Fig. 4g).
This neuropathological study revealed a broad spectrum of focal developmental abnormalities and pre- and perinatally acquired lesions in 92% of the brains of autistic subjects and striking inter-individual differences in the type and topography of changes. Evidence that different features of autism are caused by different genes associated with different brain regions [48] suggests a link between regional developmental alterations in the brain and different components of the autistic phenotype.
Altered neurogenesis in autism
Increased brain mass in autistic children and some autistic adults [89], increase in the numerical density of neurons [13, 14], reduced size of neurons [7] and brain structure-specific delay of neuronal growth [111] indicate alterations in neuronal and brain growth in autistic individuals. The subventricular zone of the lateral ventricles [26] and the dentate gyrus [33] are active sites of neurogenesis in adult humans. Several of our findings support the hypothesis of altered neurogenesis in autistic subjects. The increased thickness of the subependymal cell layer, subependymal nodular dysplasia, abnormal growth of the dentate nucleus and dysplasia of the granule layer in the dentate gyrus, detected in this study, appear to be signs of abnormal neurogenesis in the brains of three autistic subjects. Subependymal nodules were reported in approximately 80% of patients with tuberous sclerosis, a disorder that is highly associated with epilepsy, autism and mental retardation [73]. Tuberous sclerosis nodules were detected in one fetus [12], suggesting that fetal development of subependymal nodules can lead to the early onset of epilepsy that was diagnosed at the age of 14 months in a neuropathologically examined autistic male. The subependymal nodules detected in this autistic male’s brain are partially similar to tubers seen in subjects diagnosed with tuberous sclerosis [24]. The cause of subependymal nodular dysplasia in the examined subject is unknown. In the reported subjects, bilateral periventricular nodules are linked to mutations of the filamin A (FLNA) gene located on chromosome Xp28. Filamin A is an actin-crosslinking protein that is essential for cell locomotion [16], and nodule formation might be related to a defect in cell migration. The presence of miniature nodules that were built of poorly differentiated small neurons within the subependymal cell layer and an increase in nodular size with signs of growth and differentiation of neurons suggests that neurogenesis, differentiation and maturation of neurons were in progress within the subependymal germinal matrix of the 7-year-old autistic child. This interpretation of subependymal nodule genesis is consistent with lineage studies demonstrating that cells in nodules express cellular markers that are typical for progenitors derived from the subventricular germinal zone [35, 67]. However, in contrast to the subependymal nodules seen in subjects with tuberous sclerosis, in the examined autistic subject, the nodules seen were small (from 258 to 3,310 μm in diameter), and did not have the characteristic ovoid or polygonal giant cells, 80–150 μm in diameter, giant cells with multiple and peripherally displaced nuclei [25], or balloon cells, which are considered the sine qua non histopathological features of the cortical tubers and subependymal nodules observed in tuberous sclerosis [73].
The enlarged caudate nucleus detected in the brain of the 7-year-old autistic subject is consistent with MRI reports documenting an increased volume of basal ganglia, including the caudate, in autism [54, 55, 66, 99]. A disproportionate increase of the caudate nucleus volume [66] suggests that in brains of some autistic individuals, extended neurogenesis within the subependymal cell layer may contribute to abnormal growth of the caudate nucleus. A similar process has been observed in the brains of people with Huntington disease, showing enhanced neurogenesis in the subependymal layer and suggesting renewal of the neuronal population in a degenerating caudate nucleus [26]. The caudate nucleus is a part of the fronto-striatal network involved in several functional domains that are impaired in autism, including lower order repetitive motor behavior; intense circumscribed patterns of interests and higher order rituals and compulsions [41], and defects in cognitive functions [19, 109], planning and problem-solving skills [78, 98], short- and long-term memory [40] and learning [88].
Defective migration in autism
Heterotopia is a sign of altered migration leading to an abnormal distribution of gray matter nodular masses with disorganized or rudimentary lamination within the periventricular area (periventricular heterotopia) or subcortical white matter (subcortical heterotopia) [2]. In the examined cohorts, heterotopias were detected in the brains of four autistic subjects and in the brain of one control subject. Heterotopias are associated with mutations in the filamin 1 gene (FLNA1) [39, 46] and the chromosome X-linked DCX gene that codes for doublecortin, a protein expressed during brain development in migrating neurons, and in the cortical plate [29, 44, 45], which is involved in the formation of the microtubules necessary for neuronal migration [15]. Periventricular nodular heterotopia has been reported to be associated with pharmaco-resistant seizures in 80–90% of patients [31]. In the examined cohort, two periventricular heterotopias were detected in the brain of a child with subependymal nodular dysplasia and seizures diagnosed at 14 months of age (B-6403). Early onset epilepsy, diagnosed at the age of 4.5 months, might be related to the multiple heterotopias found within the frontal inferior gyrus, vermis and cerebellar white matter, coexisting with a focal cortical dysplasia and dentate gyrus dysplasia (B-5342).
Cortical, hippocampal and cerebellar dysplasia in autism
The most common form of developmental changes detected in the examined brains was focal dysplasia, which was observed in 11 (85%) of the autistic subjects. The morphology of focal dysplasias appears to reflect signs of abnormal migration, neuronal immaturity and altered cell arrangement, resulting in focal distortion of cytoarchitecture. In spite of similarities, the dysplastic changes in the neocortex and archicortex, dentate gyrus and cornu Ammonis and cerebellum also reveal a brain structure-specific pattern of dysplastic changes in autism.
Dysplasias encompass a spectrum of changes ranging from a mild form of cortical disruption, without cellular abnormalities, to the most severe form with cortical dyslamination, with abnormal morphology of neurons and astrocytes [93, 96, 107]. Focal cortical dysplasias with giant neurons and balloon cells [107, 113] are histopathologically similar to tubers containing giant cells in tuberous sclerosis complex [25, 73], suggesting a common pathogenic basis [113]. However, activation of the mammalian target of rapamycin (mTOR) pathway observed in the tuberous sclerosis complex is not present in focal cortical dysplasia [8, 80]. The giant neurons and ballooned cells, which are histopathological features of tuberous sclerosis and focal cortical dysplasia, were absent both in the subependymal nodules and in the focal cortical dysplasia observed in the examined autistic cohort. These findings suggest that in spite of similarities, the pathomechanisms of developmental alterations are different in the examined autistic subjects than those in tuberous sclerosis heterotopias or focal cortical dysplasia. The development of the giant neuron- and balloon cell-free dysplasias observed in the autistic subjects might be related to differences in cause and/or mechanism. The detection of changes similar to focal cortical dysplasia in association with prenatal ischemia [65] or in shaken infant syndrome [74] may support these speculations.
Ectopias and dysplastic changes were reported in the brains of autistic subjects, by several groups [4, 6264, 91]. Bailey et al. [4] detected olivary dysplasia in the brain of three of the five autistic subjects, and ectopic neurons related to the olivary complex in two cases. Moreover, in the brains of four autistic subjects, cortical dysgenesis was found. In the brains of the autistic subjects, a strikingly consistent finding was cingulate cortex disordered lamination [6264, 100]. A recent study of the cingulate cortex of nine autistic subjects revealed a developmental malformation with irregular lamination in three cases, and an increased number of neurons within the subcortical white matter in two [100]. Simms et al. [100] suggest that the excessive number of neurons in the subcortical white matter reflects the lack of proper resolution of the transient zone in the developing brain of autistic subjects. Studies by Fatemi et al. [37, 38] link the migration and lamination defects to a striking reduction of reelin (by 40%) and Bcl-2 (by 34–51%) in the brains of autistic subjects. Our studies along with others’ suggest that in the majority of autistic subjects, heterotopias and dysplastic changes are the local sign of general developmental defects of migration with a broad spectrum of topographic, morphological, and functional outcomes.
In the examined brains of autistic subjects, signs of neuronal immaturity were a common finding. Failure of maturation of neuronal precursors caused by altered expression of cytoskeletal proteins and loss of neuronal polarity results in defects in migration to the destined layer and in incorrect vertical and horizontal orientation [93]. The immaturity of dysplastic neurons is reflected in the expression of a variety of proteins and mRNA that are not present in mature neurons an altered expression of developmentally regulated cytoskeletal elements [3, 23, 61, 76], which are known to be crucial for dendrite arborization, spine formation, axon outgrowth and maintenance of cell size and shape. Reduced cell size, dendritic arborization and spine expression are characteristic of dysplastic neurons [6, 93]. Cortical dysplasias are the most epileptogenic lesions of the brain [107] and are observed in up to 25% of all epileptic surgeries [102]. More subtle cortical malformations or dysgenesis encountered in adults with epilepsy may lack the histological criteria for focal cortical dysplasia. They have been described as mild cortical dysplasia or microdysgenesis [77].
Microdysgenesis within the entorhinal cortex of the 23- and the 60-year-old autistic subjects in the examined cohort is unique because the selective deficit of neurons was limited almost exclusively to the stellate neurons in the second layer. It is possible that the observed dysgenesis is a result of defective migration of neurons to their intended destinations. The presence of a thicker molecular layer and the deeper location of islands in the entorhinal cortex of subjects with schizophrenia were previously interpreted as evidence that the stellate neurons do not reach their destinations during development, probably due to abnormal migration [36, 57]. Studies indicating the involvement of reelin and Bcl2 genes in the pathogenesis of schizophrenia [37, 47, 60] and the reduced expression of reelin and Bcl2 in people with autism suggest that these two genes play a role in abnormal brain development and contribute to the structural and functional anomalies seen in autism and schizophrenia [37].
The distortion of dentate gyrus development detected in two autistic subjects was reflected in granule cell migration into the molecular layer and formation of an additional granule cell layer. Distortion of the shape of the dentate granule cell layer with the formation of irregular circles and loops appears to be another piece of evidence suggesting abnormal neuronal migration and networking. Numerous factors up-regulate neurogenesis in the hippocampus [32], including seizures [70, 71], antidepressant drugs [59, 72] and lithium [18]. Several areas of dysplastic changes with significant deficits of pyramidal neurons were found in the CA1 sector in three autistic subjects, but thickening of the pyramidal layer and an increased packing of dysplastic neurons in the CA1 sector of the 56-year-old subject suggests a diversity of CA dysplasia patterns in autism. The lack of gliosis indicates that the observed pathology is a sign of microdysgenesis rather than an effect of hypoxic neuronal loss. A significant deficit of mature pyramidal neurons and the presence of small irregular or poorly differentiated oval neurons suggest the defect of neuronal maturation in autism.
We report a spectrum of focal developmental changes seen in the cerebellum of eight autistic subjects, including nodular (lobe X) [97] dysplasia in the cerebellum in five, vermal dysplasia in one, severe focal hypoplasia in one, and heterotopias in one other subject. The presence of heterotopias only in one control subject is evidence of a strong tendency for focal developmental changes of cerebellar microarchitecture that were present in 61% of the autistic subjects. Flocculonodular dysplasia affecting almost the entire lobe indicates that mechanisms leading to focal dysplasia, which were present in five (38%) of the autistic subjects, show extremely strong topographic predilection. The observed focal dysplasia was associated with profound local disorganization of granule cells, Purkinje cells and molecular layers limited to a small cerebellar compartment receiving major projections from the vestibular complex involved in the oculomotor and postural system. Similar cerebellar dysplastic changes classified as heterotaxias (clusters of poorly organized mixed cells) were identified in 14% of normal infants but in 83% of infants with trisomy of different chromosomes [92]. The presence within the dysplastic nodule of both GABAergic Purkinje cells produced from the cerebellar ventricular zone, and the glutamatergic granule neurons produced from the rhombic lip, and the preservation of the cytoarchitecture in the adjacent cerebellar folia suggest that the final steps of migration and networking are disturbed mainly or exclusively in the nodule of the majority of autistic subjects. The characteristic feature distinguishing lobule X from the other lobules is the abundance of the transcription factor Tbr2 positive unipolar brush cells (UBCs) [30, 34], which amplify inputs from vestibular ganglia and nuclei, by spreading and prolonging excitation within the internal granular layer [84]. Abnormal networking of Purkinje cells, granule neurons, and UBCs may contribute to altered cerebellar coordination of locomotion and motor learning and planning, as well as of higher cognitive processing [58]. Flocculonodular dysplasia appears to be another sign of the mosaic of local developmental defects, most likely predetermined by the spatial patterning of germinal zones in developing rhombic lip [110], and coexisting with more general developmental defects resulting in the accelerated growth of the brain in early childhood [89], minicolumn pathology [13, 14], reduced neuron volume [7, 108, 111], and desynchronized neuronal growth in many brain regions [111] observed in autism.
Identification of sub-groups with signs of hyperplasia, hypoplasia and normal-sized cerebellum [95] reflects the heterogeneity of the autistic population. Piven et al. [87] reported that cerebellar volume correlates with an increased total brain volume. In the majority of autistic subjects, reduced size of the cerebellar hemisphere is observed [42, 82], but this trend is not detectable in cohorts of high-functioning autistic individuals [56]. Regional hypoplasia affects the vermis in autistic individuals relatively often [20, 22, 52] and may be associated with the deficits in attention-orienting [49, 104], stereotypic behavior and reduced exploration observed in autism [86]. In the examined autistic cohort, selective and severe hypoplasia of lobes 1–4 associated with hypoconvolution of a large portion of the dentate nucleus appears to correspond to clinically detected defects of movement coordination. These findings suggest that differences in the type, topography and severity of cerebellar developmental defects may contribute to different clinical manifestations.
In the 4–7-year-old autistic children examined in this study, the volume of the Purkinje cells was 38% smaller than that of the age-matched control group [111]. Moreover, it has been reported that Purkinje cells of the autistic subjects revealed a 40% decrease in the expression of glutamic acid decarboxylase 67 (GAD67) mRNA [114]. In autism, the basket cells provide an increased GABAergic feed-forward inhibition to Purkinje cells. The result could be disruption in the timing of Purkinje cell firings and altered inhibition of the cerebellar nuclei, which could directly affect cerebello-cortical output and contribute to the changes in motor behavior and cognition observed in autism [115]. These findings and the reduced volume (by 26%) of the neurons of the dentate nucleus seen in the 4–7-year-old autistic children [111] suggest that in autism, interactions between the Purkinje cells and dentate nucleus are modified on the structural, molecular and functional levels.
The (a) detected changes within the subependymal cell layer with subependymal nodular dysplasia, (b) subcortical and periventricular heterotopias and (c) neocortex, archicortex, dentate gyrus, cornu Ammonis and cerebellar dysplasia reflect focal modification of neurogenesis, migration and alterations of the cytoarchitecture of brain cortex, subcortical structures and cerebellum in autism. Detection of dysplastic changes only in one control brain and of the broad spectrum of focal developmental alterations in the brains of 92% of the autistic subjects indicates that focal changes are a reflection of global developmental abnormalities and that regional changes may have their own contribution to the clinical heterogeneity of autism.
Acknowledgments
This study was supported in part by funds from the New York State Office of Mental Retardation and Developmental Disabilities, a grant from the Department of Defense Autism Spectrum Disorders Research Program (AS073234, Program Project; J.W., T.W., A.C.), a grant from Autism Speaks (Princeton, NJ), and grant R01 HD43960 (J.W.) from the National Institutes of Health, National Institute of Child Health and Human Development. Tissue and clinical records’ acquisition was coordinated by the Autism Tissue Program (Princeton, NJ; Directors: Jane Pickett, Ph.D. and Daniel Lightfoot, Ph.D.). The tissue was obtained from the Harvard Brain Tissue Resource Center, Belmont, MA, supported in part by PHS grant number R24-MH 068855; the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore; and the Brain Bank for Developmental Disabilities and Aging of the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY. We thank Drs. Helmut Hainsen and Christoph Schmitz for help in implementation of the celloidin protocol, and Mrs. Jadwiga Wegiel, Cathy Wang and En Wu Zhang for histology. We are deeply indebted to the families of the tissue donors who have made this study possible.
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
1. Diagnostic and statistical manual of mental disorders DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
2. Andrade DM. Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain. Hum Genet. 2009;126:173–193. [PubMed]
3. Avila J, Dominguez J, Diaz-Nido J. Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development. Int J Dev Biol. 1994;38:13–25. [PubMed]
4. Bailey AP, Luthert A, Dean B, et al. A clinicopathological study of autism. Brain. 1998;121:889–905. [PubMed]
5. Bailey AR, Giunta BN, Obregon D, et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med. 2008;1:338–344. [PMC free article] [PubMed]
6. Barth PG. Disorders of neuronal migration. Can J Neurol Sci. 1987;14:1–16. [PubMed]
7. Bauman ML, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology. 1985;35:866–867. [PubMed]
8. Baybis M, Yu J, Lee A, Golden JA, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol. 2004;56:478–487. [PubMed]
9. Bobinski M, Leon MJ, Convit A, et al. MRI of entorhinal cortex in mild Alzheimer’s disease. Lancet. 1999;353:38–40. [PubMed]
10. Boddaert N, Zilbovicius M, Philipe A, et al. MRI findings in 77 children with non-syndromic autistic disorder. PLoS One. 2009;4:e4415. [PMC free article] [PubMed]
11. Bruce S, Nyberg F, Melén E, et al. The protective effect of farm animal exposure on childhood allergy is modified by NPSR1 polymorphisms. J Med Genet. 2009;46:159–167. [PubMed]
12. Carlson BA, Houser OW, Gomez MR. Brain imaging in the tuberous sclerosis complex. In: Gomez M, Sampson J, Whittemore V, editors. Tuberous sclerosis complex. 3. New York: Oxford University Press; 1999. pp. 85–93.
13. Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in autism. Neurology. 2002;58:428–432. [PubMed]
14. Casanova MF, Kooten IAE, Switala EH, et al. Minicolumnar abnormalities in autism. Acta Neuropathol. 2006;112:287–303. [PubMed]
15. Caspi M, Atlas R, Kantor A, Sapir T, Reiner O. Interaction between LIS1 and doublecortin, two lissencephaly gene products. Hum Mol Genet. 2000;9:2205–2213. [PubMed]
16. Chang BS, Walsh CA. The genetic basis of human cerebral cortical malformations. In: Runge MS, Patterson C, editors. Principles of molecular medicine. Totowa, NJ: Human Press Inc; 2009. pp. 1073–1079.
17. Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006;13:171–181. [PubMed]
18. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji NH. Enhancement of hippocampal neurogenesis by lithium. J Neurochem. 2000;75:1729–1734. [PubMed]
19. Chow TW, Cummings JL. Frontal-subcortical circuits. In: Miller BL, Cummings JL, editors. The human frontal lobes: functions and disorders. New York: Guilford Press; 1999. pp. 3–26.
20. Ciesielski KT, Harris RJ, Hart BL, Pabst H. Cerebellar hypoplasia and frontal lobe cognitive deficits in disorders of early childhood. Neuropsychologia. 1997;35:643–655. [PubMed]
21. Courchesne E, Hesselink JR, Jernigan TL, Yeung-Courchesne R. Abnormal neuroanatomy in a nonretarded person with autism. Unusual findings with magnetic resonance imaging. Arch Neurol. 1987;44:335–341. [PubMed]
22. Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med. 1988;318:1349–1354. [PubMed]
23. Crino PB, Trojanowski JQ, Eberwine J. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol. 1997;93:619–627. [PubMed]
24. Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology. 1999;53:1384–1390. [PubMed]
25. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol. 2002;12:212–233. [PubMed]
26. Curtis MA, Penney EB, Pearson J, Dragunow M, Connor B, Faull RL. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington’s disease human brain. Neuroscience. 2005;132:777–788. [PubMed]
27. Damasio H, Maurer RG, Damasio AR, Chui HC. Computerized tomographic scan findings in patients with autistic behavior. Arch Neurol. 1980;37:504–510. [PubMed]
28. Department of Health and Human Services (2007) Morbidity and mortality weekly report. In: Department of Health and Human Services, Centers for Disease Control and Prevention, pp 1–28.
29. des Portes V, Francis F, Pinard JM, et al. Doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH) Hum Mol Genet. 1998;7:1063–1070. [PubMed]
30. Diño MR, Willard FH, Mugnaini E. Distribution of unipolar brush cells and other calretinin immunoreactive components in the mammalian cerebellar cortex. J Neurocytol. 1999;28:99–123. [PubMed]
31. Dubeau F, Tampieri D, Lee N, et al. Periventricular and subcortical nodular heterotopia: a study of 33 patients. Brain. 1995;118:1273–1287. [PubMed]
32. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 2001;25:836–844. [PubMed]
33. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313–1317. [PubMed]
34. Englund C, Kowalczyk T, Daza RAM, et al. Unipolar brush cells of the cerebellum are produced in the rhombic lip and migrate through developing white matter. J Neurosci. 2006;26:9184–9195. [PubMed]
35. Ess KC, Kamp CA, Tu BP, Gutmann DH. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex. Neurology. 2005;64:1446–1449. [PubMed]
36. Falkai P, Schneider-Axmann T, Honer WG. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry. 2000;47:937–943. [PubMed]
37. Fatemi SH, Kroll JL, Stary JM. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport. 2001;12:3209–3215. [PubMed]
38. Fatemi SH, Stary JM, Halth AR, Realmuto GR. Dysregulation of reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord. 2001;31:529–535. [PubMed]
39. Fox JW, Lamperti ED, Eksioglu YZ. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron. 1998;21:1315–1325. [PubMed]
40. Fuh JL, Wang SJ. Caudate hemorrhage: clinical features, neuropsychological assessments and radiological findings. Clin Neurol Neurosurg. 1995;97:296–299. [PubMed]
41. Gabriels RL, Cuccaro ML, Hill DE, Ivers BJ, Goldson E. Repetitive behaviors in autism: relationships with associated clinical features. Res Dev Disabil. 2005;26:169–181. [PubMed]
42. Gaffney GR, Tsai LY, Kuperman S, Minchin S. Cerebellar structure in autism. Am J Dis Child. 1987;141:1330–1332. [PubMed]
43. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol. 1996;38:191–202. [PubMed]
44. Gleeson JG, Allen KM, Fox JW. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell. 1998;92:63–72. [PubMed]
45. Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 1999;23:257–271. [PubMed]
46. Gorlin JB, Henske E, Warren ST. Actin-binding protein (ABP-280) filamin gene (FLN) maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. Genomics. 1993;17:496–498. [PubMed]
47. Guidotti A, Auta J, Davis JM. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry. 2000;57:1061–1069. [PubMed]
48. Happe F, Ronald A, Plomin R. Time to give up on a single explanation for autism. Nat Neurosci. 2006;9:1218–1220. [PubMed]
49. Harris NS, Courchesne E, Townsend J, Carper RA, Lord C. Neuroanatomic contributions to slowed orienting of attention in children with autism. Brain Res Cogn Brain Res. 1999;8:61–71. [PubMed]
50. Hashimoto T, Tayama M, Mori K, Fujino K, Miyazaki M, Kuroda Y. Magnetic resonance imaging in autism: preliminary report. Neuropediatrics. 1989;20:142–146. [PubMed]
51. Hashimoto T, Tayama M, Miyazaki M, Murakawa K, Kuroda Y. Brainstem and cerebellar vermis involvement in autistic children. J Child Neurol. 1993;8:149–153. [PubMed]
52. Hashimoto T, Tayama M, Murakawa K, et al. Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord. 1995;25:1–18. [PubMed]
53. Heinsen H, Arzberger T, Schmitz C. Celloidin mounting (embedding without infiltration)—a new, simple and reliable method for producing serial sections of high thickness through complete human brains and its application to stereological and immunohistochemical investigations. J Chem Neuroanat. 2000;20:49–59. [PubMed]
54. Herbert MR, Ziegler DA, Deutsch CK. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain. 2003;126:1182–1192. [PubMed]
55. Hollander E, Anagnostou E, Chaplin W. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry. 2005;58:226–232. [PubMed]
56. Holttum JR, Minshew NJ, Sanders RS, Phillips NE. Magnetic resonance imaging of the posterior fossa in autism. Biol Psychiatry. 1992;32:1091–1101. [PubMed]
57. Honer WG, Bassett AS, Falkai P, Beach TG, Lapointe JS. A case study of temporal lobe development in familial schizophrenia. Psychol Med. 1996;26:191–195. [PMC free article] [PubMed]
58. Ito M. Control of mental activities by internal models in the cerebellum. Nat Rev Neurosci. 2008;9:304–313. [PubMed]
59. Jacobs BL, Fornal CA. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology. 1999;21:9S–15S. [PubMed]
60. Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry. 2000;48:641–650. [PubMed]
61. Kaplan MP, Chin SS, Fliegner KH, Liem RK. Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain. J Neurosci. 1990;10:2735–2748. [PubMed]
62. Kemper TL (1988) Neuroanatomic studies of dyslexia and autism. In: Disorders of the developing nervous system: changing views on their origins, diagnosis, and treatments. Alan R. Liss Inc, New York, pp 125–154.
63. Kemper TL, Bauman ML. The contribution of neuropathologic studies to the understanding of autism. Behav Neurol. 1993;11:175–187. [PubMed]
64. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol. 1998;57:645–652. [PubMed]
65. Kremer S, Saint MA, Minotti L, et al. Focal cortical dysplasia possibly related to a probable prenatal ischemic injury. J Neuroradiol. 2002;29:200–203. [PubMed]
66. Langen M, Durston S, Staal WG, Palmen SJ, Engelan H. Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol Psychiatry. 2007;62:262–266. [PubMed]
67. Lee A, Maldonado M, Baybis M, et al. Markers of cellular proliferation are expressed in cortical tubers. Ann Neurol. 2003;53:668–673. [PubMed]
68. Lopez-Hurtado E, Prieto JJ. A microscopic study of language-related cortex in autism. Am J Biochem Biotechnol. 2008;4:130–145.
69. Lord C, Risi S, Lambrecht L, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000;30:205–223. [PubMed]
70. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47:1043–1049. [PubMed]
71. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20:9104–9110. [PubMed]
72. Manev H, Uz T, Smalheiser NR, Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol. 2001;411:67–70. [PubMed]
73. Marcotte L, Crino PB. The neurobiology of the tuberous sclerosis complex. Neuromol Med. 2006;8:531–546. [PubMed]
74. Marin-Padilla M, Parisi JE, Armstrong DL, Sargent SK, Kaplan JA. Shaken infant syndrome: developmental neuropathology, progressive cortical dysplasia, and epilepsy. Acta Neuropathol. 2002;103:321–332. [PubMed]
75. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Human Gen. 2008;82:477–488. [PubMed]
76. Matus A. Microtubule-associated proteins: their potential role in determining neuronal morphology. Ann Rev Neurosci. 1988;11:29–44. [PubMed]
77. Meencke HJ, Janz D. The significance of microdysgenesia in primary generalized epilepsy: an answer to the considerations of Lyon and Gastaut. Epilepsia. 1985;26:368–371. [PubMed]
78. Mendez MF, Adams NL, Lewandowski KS. Neurobehavioral changes associated with caudate lesions. Neurology. 1989;39:349–354. [PubMed]
79. Miles JH, Takahashi TN, Bagby S, et al. Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A. 2005;135:171–180. [PubMed]
80. Miyata H, Chiang AC, Vinters H. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol. 2004;56:510–519. [PubMed]
81. Muller RA. The study of autism as a distributed disorder. Ment Retard Dev Disabil Res Rev. 2007;13:85–95. [PMC free article] [PubMed]
82. Murakami W, Courchesne E, Press GA, Yeung-Courchesne R, Hesselink JR. Reduced cerebellar hemisphere size and its relationship to vermal hypoplasia in autism. Arch Neurol. 1989;46:689–694. [PubMed]
83. Newschaffer CJ, Fallin D, Lee NL. Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiol Rev. 2002;24:137–153. [PubMed]
84. Nunzi MG, Birnstiel S, Bhattacharyya BJ, Slater NT, Mugnaini E. Unipolar brush cells form a glutamatergic projection system within the mouse cerebellar cortex. J Comp Neurol. 2001;434:329–341. [PubMed]
85. Palmen SJ, Engelan H, Hof PR, Schmitz C. Neuropathological findings in autism. Brain. 2004;127:2572–2583. [PubMed]
86. Pierce K, Courchesne E. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry. 2001;49:655–664. [PubMed]
87. Piven J, Saliba K, Bailey J, Arndt S. An MRI study of autism: the cerebellum revisited. Neurology. 1997;49:546–551. [PubMed]
88. Poldrack RA, Prabhakaran V, Seger CA, Gabrieli JD. Striatal activation during acquisition of a cognitive skill. Neuropsychology. 1999;13:564–574. [PubMed]
89. Redcay E, Courchesne E. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry. 2005;58:1–9. [PubMed]
90. Ritvo ER, Freeman BJ, Scheibel AB, et al. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry. 1986;143:862–866. [PubMed]
91. Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J. Embryological origin of autism: developmental abnormalities of the cranial nerve nuclei. J Comp Neurol. 1996;370:247–261. [PubMed]
92. Rorke LB, Fogelson MH, Riggs HE. Cerebellar heterotopia in infancy. Dev Med Child Neurol. 1968;10:644–650. [PubMed]
93. Rorke LB. A perspective: the role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J Neuropathol Exp Neurol. 1994;53:105–117. [PubMed]
94. Rutter M, Bailey A, Bolton P, Le Couteur A. Autism and known medical conditions: myth and substance. J Child Psychol Psychiatry. 1994;35:311–322. [PubMed]
95. Saitoh O, Courchesne E. Magnetic resonance imaging study of the brain in autism. Psychiatry Clin Neurosci. 1998;52(Suppl):S219–S222. [PubMed]
96. Sarnat HB, Benjamin DR, Siebert JR, et al. Cerebral dysgenesis: embryology and clinical expression. Cell. 1992;69:581–595. [PubMed]
97. Schmahmann JD, Doyon J, McDonald D, et al. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. Neuroimage. 1999;10:233–260. [PubMed]
98. Schmidtke K, Manner H, Kaufmann R, Schmolck H. Cognitive procedural learning in patients with fronto-striatal lesions. Learn Mem. 2002;9:419–429. [PubMed]
99. Sears LL, Vest C, Mohamed S, Bailey J, Ranson BJ, Piven J. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:613–624. [PubMed]
100. Simms ML, Kemper TL, Timbie CM, Bauman ML, Blatt GJ. The anterior cingulate cortex in autism: heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathol. 2009;118:673–684. [PubMed]
101. Sokol DK, Chen D, Farlow MR, et al. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol. 2006;21:444–449. [PubMed]
102. Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain. 2002;125:1719–1732. [PubMed]
103. The Autism Genome Project Consortium Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet. 2007;39:319–328. [PubMed]
104. Townsend J, Courchesne E, Covington J, et al. Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J Neurosci. 1999;19:5632–5643. [PubMed]
105. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children. I. Clinical characteristics. Pediatrics. 1991;88:1211–1218. [PubMed]
106. Tuchman RF, Rapin I. Epilepsy in autism. Lancet Neurol. 2002;1:352–358. [PubMed]
107. Usui N, Matsuda K, Mihara T, et al. MRI of cortical dysplasia-correlation with pathological findings. Neuroradiology. 2001;43:830–837. [PubMed]
108. Kooten I, Palmen SJ, Engelan CP, et al. Neurons in the fusiform gyrus are fewer and smaller in autism. Brain. 2008;131:987–999. [PubMed]
109. Voelbel GT, Bates ME, Buckman JF, Pandina G, Hendren RL. Caudate nucleus volume and cognitive performance: are they related in childhood psychopathology? Biol Psychiatry. 2006;60:942–950. [PMC free article] [PubMed]
110. Volkmann K, Rieger S, Babaryka A, Koster RW. The zebrafish cerebellar rhombic lip is spatially patterned in producing granule cell populations of different functional compartments. Dev Biol. 2008;313:167–180. [PubMed]
111. Wegiel J, Wisniewski T, Chauhan A, et al. Type, topography and sequelae of neuropathological changes shaping clinical phenotype of autism. In: Chauhan A, Chauhan V, Brown WT, et al., editors. Autism: oxidative stress, inflammation, and immune abnormalities. Boca Raton, FL: Taylor & Francis/CRC Press; 2010. pp. 1–34.
112. Weiss LA, Arking DE., The Gene Discovery Project of Johns Hopkins & the Autism Consortium A genome-wide linkage and association scan reveals novel loci for autism. Nature. 2009;461:802–811. [PMC free article] [PubMed]
113. Wolf HK, Normann S, Green AJ, et al. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions. Acta Neuropathol. 1997;93:93–96. [PubMed]
114. Yip J, Soghomonian JJ, Blatt GJ. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 2007;113:559–568. [PubMed]
115. Yip JJ, Soghomonian J, Blatt GJ. Increased GAD67 mRNA expression in cerebellar interneurons in autism: implications for Purkinje cell dysfunction. J Neurosci Res. 2008;86:525–530. [PubMed]
Articles from Springer Open Choice are provided here courtesy of
Springer